OstomyCure

Executive Summary

OstomyCure is a Norwegian medical device company developing the TIES® (Transcutaneous Implant Evacuation System), an implantable alternative to traditional ostomy bags for permanent stoma patients. The device aims to significantly improve quality of life by eliminating the need for external bags, reducing skin complications, and enabling more natural bowel control. Founded in 2016 and headquartered in Oslo, the company has completed initial feasibility studies and is preparing for first-in-human trials. With a strong preclinical proof-of-concept, OstomyCure addresses a large unmet need in the $3B+ ostomy care market, where over 1 million patients worldwide suffer from physical and psychosocial burdens of current solutions. The TIES system, if successful, could become the standard of care, driving substantial value creation in both medical and commercial terms.

Upcoming Catalysts (preview)

• Q3 2026First-in-human clinical trial initiation60% success
• Q4 2026CE marking submission50% success
• Q2 2026Strategic partnership or licensing deal40% success